Countries. If vaccines are the new global collective goods, it is not surprising that a race for them has begun. However, there are two arguments that must be kept separate. Some say that this pandemic makes us see that we necessarily ne to think globally, that we ne, in a way, a global structural policy on these global health issues. The counter-argument says that now each country is mainly concern with itself. I don’t think it is defin which argument will triumph. But if the second wins, then we really have a confrontation between countries, with all the ensuing consequences. This is likely to benefit no one in the long run. The big players currently seem to be Russia, the Unit States and China.
These Preferences Are Very Different
Where does the European Union stand in this competition? The more than promising developments for a vaccine that are list in the WHO prove that there is currently a huge effort at different levels. So sooner Switzerland Email List or later there will be an effective vaccine. By the way, at any other time in history this would have been impossible. But the crucial question is: who will have access to the vaccine and who will benefit from it? In recent months, all large countries with economic capacity have secur the rights to use vaccines or are promoting research with state companies or state participation.
Profoundly Weakens The Potential Of Democracies
The entry of the German state into the Tübingen-bas company CureVac is certainly no exception. The fact that CureVac is now going public on the US Stock Exchange also shows the transnational interconnectness AFB Directory in this area. The Unit States also has agreements with the German company BioNTech, but also with Johnson & Johnson, Sanofi and several others. Australia, Canada, Japan and many other countries have sign similar contracts. There are also numerous efforts in this direction: in Europe, for example, an alliance of Germany, France.